Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Revenues down at Stellar Biotechnologies

By   /   Friday, December 1st, 2017  /   Comments Off on Revenues down at Stellar Biotechnologies

    Print       Email
Stellar Biotechnologies reported a steep drop in revenues for its fiscal year 2017, but net losses remained flat to the previous year at $5.03 million. Revenue fell from $1.27 million in fiscal 2016 to $228,300 for the year ended Sept. 30. Expenses declined 11.8 percent to $5.45 million, for a net loss of 49 cents…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email